135 related articles for article (PubMed ID: 38899631)
1. Nirsevimab immunization's real-world effectiveness in preventing severe bronchiolitis: A test-negative case-control study.
Agüera M; Soler-Garcia A; Alejandre C; Moussalam-Merino S; Sala-Castellví P; Pons G; Penela-Sánchez D; González-Grado C; Alsina-Rosell J; Climent C; Esteva C; Fortuny C; de-Sevilla MF; García-García JJ; Brotons P; Balaguer A; Estrada J; Jordan I; Muñoz-Almagro C; Launes C
Pediatr Allergy Immunol; 2024 Jun; 35(6):e14175. PubMed ID: 38899631
[TBL] [Abstract][Full Text] [Related]
2. Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain.
Zornoza Moreno M; Pérez Martín JJ; Moreno MCG; Abellán MPR
Hum Vaccin Immunother; 2024 Dec; 20(1):2357439. PubMed ID: 38857859
[TBL] [Abstract][Full Text] [Related]
3. Nirsevimab for the prevention of respiratory syncytial virus disease in children. Statement of the Spanish Society of Paediatric Infectious Disease (SEIP).
Francisco L; Cruz-Cañete M; Pérez C; Couceiro JA; Otheo E; Launes C; Rodrigo C; Jiménez AB; Llorente M; Montesdeoca A; Rumbao J; Calvo C; Frago S; Tagarro A
An Pediatr (Engl Ed); 2023 Oct; 99(4):257-263. PubMed ID: 37743207
[TBL] [Abstract][Full Text] [Related]
4. Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol.
Mallah N; Ares-Gómez S; Pardo-Seco J; Malvar-Pintos A; Santiago-Pérez MI; Pérez-Martínez O; Otero-Barrós MT; Suárez-Gaiche N; Kramer R; Jin J; Platero-Alonso L; Alvárez-Gil RM; Ces-Ozores OM; Nartallo-Penas V; Mirás-Carballal S; Piñeiro-Sotelo M; González-Pérez JM; Rodríguez-Tenreiro C; Rivero-Calle I; Salas A; Durán-Parrondo C; Martinón-Torres F
Hum Vaccin Immunother; 2024 Dec; 20(1):2348135. PubMed ID: 38738683
[TBL] [Abstract][Full Text] [Related]
5. Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.
Moline HL; Tannis A; Toepfer AP; Williams JV; Boom JA; Englund JA; Halasa NB; Staat MA; Weinberg GA; Selvarangan R; Michaels MG; Sahni LC; Klein EJ; Stewart LS; Schlaudecker EP; Szilagyi PG; Schuster JE; Goldstein L; Musa S; Piedra PA; Zerr DM; Betters KA; Rohlfs C; Albertin C; Banerjee D; McKeever ER; Kalman C; Clopper BR; ; McMorrow ML; Dawood FS
MMWR Morb Mortal Wkly Rep; 2024 Mar; 73(9):209-214. PubMed ID: 38457312
[TBL] [Abstract][Full Text] [Related]
6. Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.
Griffin MP; Yuan Y; Takas T; Domachowske JB; Madhi SA; Manzoni P; Simões EAF; Esser MT; Khan AA; Dubovsky F; Villafana T; DeVincenzo JP;
N Engl J Med; 2020 Jul; 383(5):415-425. PubMed ID: 32726528
[TBL] [Abstract][Full Text] [Related]
7. Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023-January 2024.
Paireau J; Durand C; Raimbault S; Cazaubon J; Mortamet G; Viriot D; Milesi C; Daudens-Vaysse E; Ploin D; Tessier S; Vanel N; Chappert JL; Levieux K; Ollivier R; Daoudi J; Coignard B; Leteurtre S; Parent-du-Châtelet I; Vaux S
Influenza Other Respir Viruses; 2024 Jun; 18(6):e13311. PubMed ID: 38840301
[TBL] [Abstract][Full Text] [Related]
8. Respiratory syncytial virus-associated hospitalizations among children: an Italian retrospective observational study.
Fortunato F; Campanozzi A; Maffei G; Arena F; Carri VD; Rollo T; Lopalco PL; Martinelli D
Ital J Pediatr; 2024 Mar; 50(1):45. PubMed ID: 38454523
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Respiratory Syncytial Virus Immunoprophylaxis in Reducing Bronchiolitis Hospitalizations Among High-Risk Infants.
Wu P; Escobar GJ; Gebretsadik T; Carroll KN; Li SX; Walsh EM; Mitchel EF; Sloan C; Dupont WD; Yu C; Horner JR; Hartert TV
Am J Epidemiol; 2018 Jul; 187(7):1490-1500. PubMed ID: 29351636
[TBL] [Abstract][Full Text] [Related]
10. Impact of universal immunization program with monoclonal antibody nirsevimab on reducing the burden of serious bronchiolitis that need pediatric intensive care.
Alejandre C; Penela-Sánchez D; Alsina J; Agüera M; Soler A; Moussalam S; Muñoz-Almagro C; Brotons P; Cambra FJ; Forner OR; Balaguer M; Launes C; Jordan I
Eur J Pediatr; 2024 Jun; ():. PubMed ID: 38910199
[TBL] [Abstract][Full Text] [Related]
11. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants.
Drysdale SB; Cathie K; Flamein F; Knuf M; Collins AM; Hill HC; Kaiser F; Cohen R; Pinquier D; Felter CT; Vassilouthis NC; Jin J; Bangert M; Mari K; Nteene R; Wague S; Roberts M; Tissières P; Royal S; Faust SN;
N Engl J Med; 2023 Dec; 389(26):2425-2435. PubMed ID: 38157500
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials.
Simões EAF; Madhi SA; Muller WJ; Atanasova V; Bosheva M; Cabañas F; Baca Cots M; Domachowske JB; Garcia-Garcia ML; Grantina I; Nguyen KA; Zar HJ; Berglind A; Cummings C; Griffin MP; Takas T; Yuan Y; Wählby Hamrén U; Leach A; Villafana T
Lancet Child Adolesc Health; 2023 Mar; 7(3):180-189. PubMed ID: 36634694
[TBL] [Abstract][Full Text] [Related]
13. RSV associated hospitalizations in children in Karachi, Pakistan: Implications for vaccine prevention strategies.
Ali A; Yousafzai MT; Waris R; Jafri F; Aziz F; Abbasi IN; Zaidi A
J Med Virol; 2017 Jul; 89(7):1151-1157. PubMed ID: 28092107
[TBL] [Abstract][Full Text] [Related]
14. Hospitalization for respiratory syncytial virus bronchiolitis and disease severity in twins.
Dotan M; Ashkenazi-Hoffnung L; Samra Z; Livni G; Yarden-Bilavsky H; Amir J; Bilavsky E
Isr Med Assoc J; 2013 Nov; 15(11):701-4. PubMed ID: 24511652
[TBL] [Abstract][Full Text] [Related]
15. Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
Jones JM; Fleming-Dutra KE; Prill MM; Roper LE; Brooks O; Sánchez PJ; Kotton CN; Mahon BE; Meyer S; Long SS; McMorrow ML
MMWR Morb Mortal Wkly Rep; 2023 Aug; 72(34):920-925. PubMed ID: 37616235
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of respiratory syncytial virus bronchiolitis in hospitalized infants in Greece.
Tsolia MN; Kafetzis D; Danelatou K; Astral H; Kallergi K; Spyridis P; Karpathios TE
Eur J Epidemiol; 2003; 18(1):55-61. PubMed ID: 12705624
[TBL] [Abstract][Full Text] [Related]
17. Respiratory Syncityal Virus A and B: three bronchiolitis seasons in a third level hospital in Italy.
Ciarlitto C; Vittucci AC; Antilici L; Concato C; Di Camillo C; Zangari P; Villani A
Ital J Pediatr; 2019 Aug; 45(1):115. PubMed ID: 31462274
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological shifts in bronchiolitis patterns and impact of the COVID-19: A two-season comparative study.
Presti S; Manti S; Gammeri C; Parisi GF; Papale M; Leonardi S
Pediatr Pulmonol; 2024 May; 59(5):1298-1304. PubMed ID: 38353390
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study.
Ares-Gómez S; Mallah N; Santiago-Pérez MI; Pardo-Seco J; Pérez-Martínez O; Otero-Barrós MT; Suárez-Gaiche N; Kramer R; Jin J; Platero-Alonso L; Alvárez-Gil RM; Ces-Ozores OM; Nartallo-Penas V; Mirás-Carballal S; Piñeiro-Sotelo M; Malvar-Pintos A; González-Pérez JM; Rodríguez-Tenreiro-Sánchez C; Rivero-Calle I; Salas A; Durán-Parrondo C; Martinón-Torres F;
Lancet Infect Dis; 2024 Apr; ():. PubMed ID: 38701823
[TBL] [Abstract][Full Text] [Related]
20. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy.
Bradley JP; Bacharier LB; Bonfiglio J; Schechtman KB; Strunk R; Storch G; Castro M
Pediatrics; 2005 Jan; 115(1):e7-14. PubMed ID: 15629968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
